Article > FDA advisors back Merck & Co's ragweed allergy pill
Sunday, June 8, 2014 News World News Free news headlines binge drinking Free RSS feed Reprints Magazine Overview Latest Issue Business Insights Subscribe Have your say Advertise in Magazine Download Media Pack Features Calendar 2014 Reprints NHS Payers Visions JobSearch Find a job Latest People List a vacancy online Get jobs by email Manage binge drinking job postings Recruiter directory Rates Contacts Competitions Clinical Researcher Communications Team Marketer Medical Science Liaison Partnerships In Health Awards binge drinking Sales Awards US Clinical Researcher Events/Meetings Partnerships In Health Networking PharmaTimes Directors' Club PharmaTimes Webinars SOPHIE Reports binge drinking Overview Contents Order Form Gallery Advertise Advertise in Magazine Advertise Online Advertise Recruitment Subscribe About Us World News Free news headlines Free RSS feed
The FDA is assessing Ragwitek for the treatment of ragweed pollen binge drinking induced allergic rhinitis, with or without binge drinking conjunctivitis, in adults 18 to 65 years of age, and a decision is expected binge drinking during the first half of this year.
Analysts are expecting binge drinking the drug to generate peak sales of around $300 million, although Reuters reports binge drinking that Morningstar analyst Damien Conover believes they could hit $1 billion if enough patients favour the pill over the alternative option of injections.
JobSearch
Nanobiotix heavy metal treatment rocks ASCO
Content Online News Magazine JobSearch Competitions Events/Meetings Information About us Authors Advertise with us Contact us How to find us Cookies Privacy Policy Editorial Policy Connect Subscribe to our YouTube channel Add us as a Flickr contact
Sunday, June 8, 2014 News World News Free news headlines binge drinking Free RSS feed Reprints Magazine Overview Latest Issue Business Insights Subscribe Have your say Advertise in Magazine Download Media Pack Features Calendar 2014 Reprints NHS Payers Visions JobSearch Find a job Latest People List a vacancy online Get jobs by email Manage binge drinking job postings Recruiter directory Rates Contacts Competitions Clinical Researcher Communications Team Marketer Medical Science Liaison Partnerships In Health Awards binge drinking Sales Awards US Clinical Researcher Events/Meetings Partnerships In Health Networking PharmaTimes Directors' Club PharmaTimes Webinars SOPHIE Reports binge drinking Overview Contents Order Form Gallery Advertise Advertise in Magazine Advertise Online Advertise Recruitment Subscribe About Us World News Free news headlines Free RSS feed
The FDA is assessing Ragwitek for the treatment of ragweed pollen binge drinking induced allergic rhinitis, with or without binge drinking conjunctivitis, in adults 18 to 65 years of age, and a decision is expected binge drinking during the first half of this year.
Analysts are expecting binge drinking the drug to generate peak sales of around $300 million, although Reuters reports binge drinking that Morningstar analyst Damien Conover believes they could hit $1 billion if enough patients favour the pill over the alternative option of injections.
JobSearch
Nanobiotix heavy metal treatment rocks ASCO
Content Online News Magazine JobSearch Competitions Events/Meetings Information About us Authors Advertise with us Contact us How to find us Cookies Privacy Policy Editorial Policy Connect Subscribe to our YouTube channel Add us as a Flickr contact
No comments:
Post a Comment